相似文献
1
Human airway epithelial cells express a functional IL-5 receptor.
Allergy. 2020 Aug;75(8):2127-2130. doi: 10.1111/all.14297. Epub 2020 Apr 14.
2
Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells.
J Biol Chem. 2007 Apr 6;282(14):10172-9. doi: 10.1074/jbc.M611210200. Epub 2007 Feb 6.
3
IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells.
J Allergy Clin Immunol. 2010 Aug;126(2):366-74, 374.e1-8. doi: 10.1016/j.jaci.2010.05.015. Epub 2010 Jul 10.
4
Interleukin-9 receptor expression in asthmatic airways In vivo.
Lung. 2000;178(3):149-60. doi: 10.1007/s004080000018.
5
6
Regulatory mechanisms of Th2 cytokine-induced eotaxin-3 production in bronchial epithelial cells: possible role of interleukin 4 receptor and nuclear factor-kappaB.
Ann Allergy Asthma Immunol. 2004 Oct;93(4):390-7. doi: 10.1016/S1081-1206(10)61399-3.
7
TLR2 Activation Limits Rhinovirus-Stimulated CXCL-10 by Attenuating IRAK-1-Dependent IL-33 Receptor Signaling in Human Bronchial Epithelial Cells.
J Immunol. 2016 Sep 15;197(6):2409-20. doi: 10.4049/jimmunol.1502702. Epub 2016 Aug 8.
8
IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17.
Respir Res. 2007 Jul 9;8(1):51. doi: 10.1186/1465-9921-8-51.
9
Interleukin 4 receptors on human bronchial epithelial cells. An in vivo and in vitro analysis of expression and function.
Cytokine. 1998 Oct;10(10):803-13. doi: 10.1006/cyto.1998.0365.
10
Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma.
Am J Respir Cell Mol Biol. 2002 Apr;26(4):484-90. doi: 10.1165/ajrcmb.26.4.4784.
引用本文的文献
1
Spatial Eosinophil Phenotypes as Immunopathogenic Determinants in Inflammatory Diseases.
Cells. 2025 Jun 5;14(11):847. doi: 10.3390/cells14110847.
2
Targeting IL-13 and IL-4 in Asthma: Therapeutic Implications on Airway Remodeling in Severe Asthma.
Clin Rev Allergy Immunol. 2025 Apr 21;68(1):44. doi: 10.1007/s12016-025-09045-2.
3
Asthma Associated Cytokines Regulate Gasdermin A and Gasdermin B Expression by Human Bronchial Epithelial Cells.
Clin Exp Allergy. 2025 Jul;55(7):586-588. doi: 10.1111/cea.70042. Epub 2025 Mar 31.
4
Lung IL-13 gene signatures are associated with raised tissue eosinophils in COPD.
Respir Res. 2025 Mar 25;26(1):114. doi: 10.1186/s12931-025-03177-x.
5
Depletion of eosinophils during sensitization but not challenge phase in mice blocks the development of food allergy early in life.
J Immunol. 2025 Apr 1;214(4):582-594. doi: 10.1093/jimmun/vkae044.
6
Time is lung: higher preservation of lung function in severe asthma patients after earlier mepolizumab treatment.
ERJ Open Res. 2025 Feb 3;11(1). doi: 10.1183/23120541.00211-2024. eCollection 2025 Jan.
7
Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action.
J Asthma Allergy. 2025 Jan 14;18:33-57. doi: 10.2147/JAA.S496630. eCollection 2025.
8
A RESPONSE to antiIL-5 therapy in comorbid patients with chronic rhinosinusitis with nasal polyps and severe asthma: Study protocol.
J Allergy Clin Immunol Glob. 2024 Sep 17;4(1):100343. doi: 10.1016/j.jacig.2024.100343. eCollection 2025 Feb.
9
Eosinophil-Epithelial Cell Interactions in Asthma.
Int Arch Allergy Immunol. 2024;185(11):1033-1047. doi: 10.1159/000539309. Epub 2024 Jun 17.
10
CAR T cells put the brakes on asthma.
Nat Immunol. 2024 Jun;25(6):935-937. doi: 10.1038/s41590-024-01851-8.
本文引用的文献
1
Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison.
J Allergy Clin Immunol. 2019 Jan;143(1):190-200.e20. doi: 10.1016/j.jaci.2018.08.031. Epub 2018 Sep 8.
2
The Biology of Eosinophils and Their Role in Asthma.
Front Med (Lausanne). 2017 Jun 30;4:93. doi: 10.3389/fmed.2017.00093. eCollection 2017.
3
Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.
Crit Rev Immunol. 2016;36(5):429-444. doi: 10.1615/CritRevImmunol.2017020172.
4
Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients.
J Allergy Clin Immunol. 2017 Jun;139(6):1736-1751. doi: 10.1016/j.jaci.2017.04.005.
5
Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication.
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5485-90. doi: 10.1073/pnas.1421178112. Epub 2015 Apr 6.
6
Interleukin-5 and IL-5 receptor in health and diseases.
Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(8):463-85. doi: 10.2183/pjab.87.463.
7
Chemoattractant-induced signaling via the Ras-ERK and PI3K-Akt networks, along with leukotriene C4 release, is dependent on the tyrosine kinase Lyn in IL-5- and IL-3-primed human blood eosinophils.
J Immunol. 2011 Jan 1;186(1):516-26. doi: 10.4049/jimmunol.1000955. Epub 2010 Nov 24.
8
Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability.
Blood. 2001 Oct 1;98(7):2014-21. doi: 10.1182/blood.v98.7.2014.
9
Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma.
J Allergy Clin Immunol. 1995 Nov;96(5 Pt 1):661-8. doi: 10.1016/s0091-6749(95)70265-2.
Zotero 插件